Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zhiyuan Vera Zheng"'
Publikováno v:
Neural Regeneration Research, Vol 17, Iss 7, Pp 1404-1411 (2022)
Subarachnoid hemorrhage is a devastating disease with significant mortality and morbidity, despite advances in treating cerebral aneurysms. There has been recent progress in the intensive care management and monitoring of patients with subarachnoid h
Externí odkaz:
https://doaj.org/article/130cfaf27c274333a596c3801bcdd1de
Autor:
Gang Lu, George K C Wong, Zhiyuan Vera Zheng, Junfan Chen, Hao Lyu, Sin Yu Erica Lam, Wai Yee Chan
Publikováno v:
Stroke and Vascular Neurology, Vol , Iss
Externí odkaz:
https://doaj.org/article/d42393f2452e475587c4c79697f5f4a0
Autor:
Gang Lu, Hao Lyu, Junfan Chen, George K.C. Wong, Wai-Yee Chan, Sin Yu Erica Lam, Zhiyuan Vera Zheng
Publikováno v:
Stroke and Vascular Neurology, Vol, Iss
Background and purposeSignal transducer and activator of transcription 3 (STAT3) may contribute to the proinflammation in the central nervous system diseases by modulating the microglial responses. Thus, this study was intended to investigate the eff
Autor:
Zhiyuan Vera Zheng, Wai Sang Poon, Hao Lyu, Sin Yu Erica Lam, George K.C. Wong, Ping Kuen Lam
Publikováno v:
Translational Stroke Research. 11:433-449
Neuroinflammation plays a critical role in the pathogenesis of subarachnoid hemorrhage (SAH). Microglia, as the resident immune cells, orchestrate neuroinflammation distinctly in neurological diseases with different polarization statuses. However, mi
Publikováno v:
Acta neurochirurgica. Supplement. 127
Subarachnoid hemorrhage (SAH) is a devastating stroke type. Approximately 50% of survivors suffer from the permanent disability, caused by the cognitive deficits. To enrich the pre-clinical research on the neurological deficits after SAH, we investig
Publikováno v:
Acta Neurochirurgica Supplement ISBN: 9783030046149
Subarachnoid hemorrhage (SAH) is a devastating stroke type. Approximately 50% of survivors suffer from the permanent disability, caused by the cognitive deficits. To enrich the pre-clinical research on the neurological deficits after SAH, we investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f289465aad32f44b44ffc79fb4f3048
https://doi.org/10.1007/978-3-030-04615-6_18
https://doi.org/10.1007/978-3-030-04615-6_18
Publikováno v:
Neuroimmunology and Neuroinflammation. 2019
Autor:
Kevin K.W. Wang, Camille Yim Cheung, Wai Sang Poon, Ho Yin Chan, Zhao Xiang Bian, Hao Lyu, Zhiyuan Vera Zheng, Yi Li
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 64
Parkinson’s Disease (PD) is the second most common neurodegenerative disease with the clinical characteristics of gait deficits. The classical symptomatic treatment for PD is Levodopa (L-DOPA) which brings a plethora of side effects and dosage prob